Budapest, Hungary

Ildiko Niklya

This inventor holds 2 USPTO granted patents. Top assignee: Egis Gyogyszergyar. Active years: 1988-1990.


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 2

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1988-1990

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ildiko Niklya: Innovator in Pharmaceutical Chemistry

Introduction

Ildiko Niklya is a notable inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new tranquilizing compounds. With a total of 2 patents, her work has garnered attention for its potential therapeutic applications.

Latest Patents

Niklya's latest patents include innovative compounds such as thiazolo[4,5-c]quinoline derivatives. One of her inventions relates to these derivatives as major tranquilizers, which are characterized by their unique chemical structure and potential for use in pharmaceutical compositions. Another significant patent focuses on 2-methyl-thiazolo[4,5-c]quinoline, which has been found to possess valuable central nervous depressive properties that differ from traditional benzodiazepines. These inventions highlight her commitment to advancing medical science through innovative chemical solutions.

Career Highlights

Ildiko Niklya is currently associated with Egis Gyogyszergyar, a prominent pharmaceutical company in Hungary. Her role at the company allows her to apply her expertise in developing new medications that can improve patient outcomes. Her contributions to the field have been recognized by her peers and the scientific community.

Collaborations

Niklya has collaborated with several talented individuals in her field, including Julia Timar and Gabriella Zsila. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Ildiko Niklya's work in pharmaceutical chemistry exemplifies the impact of innovative thinking in medicine. Her patents and collaborations reflect her dedication to improving healthcare through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…